Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UMBRALISIB vs URIDINE TRIACETATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UMBRALISIB vs URIDINE TRIACETATE: Safety Overview

Metric UMBRALISIB URIDINE TRIACETATE
Total FAERS Reports 293 110
Deaths Reported 30 20
Death Rate 10.2% 18.2%
Hospitalizations 97 19
Average Patient Age 69.0 yrs 50.1 yrs
% Female Patients 43.8% 58.3%
FDA Approval Date Feb 5, 2021 Dec 11, 2015
Manufacturer N/A BTG International Inc
Route N/A ORAL
Marketing Status Discontinued Prescription